France

39 articles available

The first strategic choice in a patent dispute is not where to sue. It is where to secure the evidence that will make the claim pleadable, quantifiable and commercially credible. A case may…

My forthcoming book, A Contractual Theory of FRAND: From Private Normativity to Legal Obligation in Technical Standardization, starts from a question that remains insufficiently examined in standard…

On 22 June 2026, the Court of Appeal of the UPC handed down two closely connected orders in the dispute between Valeo Systèmes d'Essuyage and the Bosch group.  Read together, they do something more…

The king is dead! Long live the king! An expression traditionally uttered at the death of a monarch to acclaim a new king on the death of his predecessor. Could it be applied to our traditional…

In an important decision rendered on 24 April 2024, the Commercial Chamber of the Cour de cassation (i.e., French Supreme Court) ruled that the assignment of a patent is not enforceable against third…

While the patentability of further medical use claim defined by a dosage regimen used to be ruled out, the EPO's Enlarged Board of Appeal has accepted them since decision G 2/08 in 2010. This…

Last week, we had the opportunity to review the texts regarding the UPC "saisie", the ex parte orders issued in the OERLIKON and C-KORE cases. In the second case, which is before the Paris local…

Yes and no, it seems. Well, yes and then no, if recent French decisions are anything to go by. In short, Hesitations Blues reign. This attitude is all the more interesting given that the question,…

My British colleague has already commented brilliantly on the UK ruling in this case from the point of view of plausibility (see here). For my part, I'd like to comment the French ruling in the same…